Whitehawk Therapeutics (WHWK) Tax Provisions (2020 - 2022)

Whitehawk Therapeutics (WHWK) posted quarterly Tax Provisions of -$9000.0 for Q4 2022, down 200.0% quarter-over-quarter from $9000.0 in Q2 2022.

Analysis

Whitehawk Therapeutics (WHWK) Tax Provisions (2020 - 2022) Analysis & Trends

Whitehawk Therapeutics (WHWK) has reported Tax Provisions for 3 consecutive years, with -$9000.0 the latest figure, recorded in Q4 2022.

In Q4 2022, Tax Provisions changed N/A year-over-year to -$9000.0; the TTM figure through Dec 2023 stood at -$9000.0 (changed N/A YoY), while the FY2025 annual figure was -$4.3 million, changed N/A from the prior year.
Tax Provisions retreated to -$9000.0 in Q4 2022 per WHWK's latest filing, from $9000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $9000.0 in Q2 2022 and bottomed at -$9000.0 in Q4 2022.
Historically, Tax Provisions has averaged $1000.0 across 3 years, with a median of $2000.0 in 2020.
On a YoY basis, Tax Provisions climbed as much as 350.0% in 2022 and fell as far as 350.0% in 2022.
Whitehawk Therapeutics' Tax Provisions stood at $2000.0 in 2020, then changed by 0.0% to $2000.0 in 2021, then sank by 550.0% to -$9000.0 in 2022.
Business Quant data shows WHWK's Tax Provisions at -$9000.0 in Q4 2022, $9000.0 in Q2 2022, and $2000.0 in Q2 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-59.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	15.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	75.45 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	13.31 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	1.90 Mn
10	Whitehawk Therapeutics	377.13 Mn	377.13 Mn	-	-

Historic Data

Download Data